header-news
Two trials for dental painkiller launch
Thursday, 29 November 2007
Two separate clinical trials of a new dental analgesic have begun at a research facility in Peru, it has been revealed.

Drug maker NeuroDiscovery said it had enrolled the first patients for its phase II tests of NSL-101 at the Peruvian University of Cayetana Heredia in Lima, with the drug being evaluated for its effectiveness when used to treat two different dental problems.
Read more...
 
Phase II psoriasis drug trials start in US
Thursday, 29 November 2007
A new drug designed to help ease the symptoms of psoriasis has begun phase II clinical trials in the US, it has been announced.

Provectus Pharmaceuticals said the tests of its topical PH-10 medicine had launched at the Mount Sinai School of Medicine in New York and predicted that it would take nine months for the study to be complete.
Read more...
 
Respiratory gas for newborns gets Australian approval
Wednesday, 28 November 2007
A new gas designed to treat newborns with hypoxic respiratory failure (HRF) has won full approval from authorities in Australia.

Ikaria Holdings announced that the country's Therapeutic Goods Administration had given the firm the right to market INOmax nitric oxide in Australia, following its previous orphan drug designation.
Read more...
 
Parkinson's drug to undergo phase III trials
Wednesday, 28 November 2007
Merck Serono is to launch phase III clinical trials of a drug designed to complement dopamine treatments for patients in the early stages of Parkinson's disease.

The firm plans to recruit more than 650 participants who have had the disease for less than five years for the study, designed to examine the safety and efficacy of different dosing regimes of its oral drug Safinamide.
Read more...
 
More...
<< Start < Prev 1 2 3 Next > End >>

Results 49 - 64 of 64